Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Making the News

 

Mediclinic shareholder invests in low-end primary care triage platform

Invenfin, the venture capital arm of Mediclinc investor Remgro, has taken a stake in a primary care provider that aims to serve the 40% of South Africans that are employed, but uninsured. National HealthCare Group says its Whatsapp triage solution can cut the cost of primary care by up to two thirds and that Remgro will now encourage roll out in its portfolio companies.
October 8, 2020

Medgate plans accelerated rollout in Germany after Rhoen JV ends

Swiss telemedicine player Medgate tells HBI that the end of its joint venture with German hospital group Rhoen Klinikum will allow it to roll out faster in Germany after the Asklepios takeover slowed down the project. HBI also checks in on the partnerships between other big hospitals and their telemedicine partners.
October 8, 2020

Unilabs new innovation chief targets consumer market

Unilabs has a new chief innovation officer who comes from recently acquired Dutch lab Saltro. Dr Esther Talboom-Kamp tells HBI about the consumer-facing and B2C platforms that she built there, but the pan-European lab group is coy about what it's now building in the space. 
October 7, 2020

Russian hospitals continue push into oncology

MD Medical has seen oncology revenues soar by 351% in H1 and this month will open its new cancer hospital for patients. It's not alone in diversifying away from self-pay activity.
September 29, 2020

French and Italian hospital groups’ diverging recovery reflects COVID experience

August activity levels for France's second-largest hospital group Elsan were ahead of 2019, while Italy's largest player San Donato is still 30% down due to a more gradual restart of electives and stricter contagion control in Lombardy, HBI can reveal. The cautiousness reflects just how hard-hit the region was.
September 24, 2020

Spire’s payor mix turned on its head in Q2

UK hospital group Spire Healthcare became a majority NHS-funded provider for the first time ever during the first half of 2020 as it became an extension of the public health system, its H1 2020 results reveal. What are the implications and how do you value a company in such unprecedented circumstances? We talk to an analyst. 
September 24, 2020

Employee testing drives 30%+ organic growth for labs through summer

COVID-19 testing for businesses, the sports industry and governments has cancelled-out and countered most falls in routine testing for the pan-European lab groups. Synlab says it signed 3,000 back-to-work testing contracts and saw 32% y-o-y organic revenue growth in June while Eurofins has 1,200 signed or in discussion. HBI examines the impact of the pandemic so far and what's next.
September 17, 2020

Mediclinic: stake in Swiss procurement disruptor “does not impact Sana agreement”

Switzerland's largest private hospital group Hirslanden's investment in a self-proclaimed 'disruptive' procurement outfit does not affect its cooperation with the procurement hub of German hospital Sana, parent company Mediclinic tells HBI. But the group has yet to reveal what it has gotten out of the cooperation with Sana. 
September 17, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us